Methylcobalamin Injection - Use Guidelines

What Is It?

Indications (When to Use Injection)

1. Pernicious anemia - intrinsic factor deficiency; oral absorption is impossible
2. Malabsorption syndromes - Crohn's disease, celiac disease, ileal resection
3. Post-gastrectomy (partial or total) - loss of intrinsic factor-secreting parietal cells
4. Diabetic peripheral neuropathy - neurotropic B12 needed parenterally for faster nerve repair
5. Peripheral neuropathy - due to B12 deficiency from any cause
6. Subacute combined degeneration of spinal cord - neurological emergency
7. Nutritional B12 deficiency - in strict vegans with severe depletion
8. Patients refusing/unable to take oral therapy
9. Schilling test flushing dose - 1000 mcg IM (used diagnostically)

Almost all cases of vitamin B12 deficiency are caused by malabsorption; therefore, parenteral injections are required for therapy. - Katzung's Basic and Clinical Pharmacology, 16th Ed.

Route of Administration

Dosage Regimens

Pernicious Anemia / Severe B12 Deficiency

• 100-1000 mcg IM daily or every other day for 1-2 weeks (to replenish body stores)
• Some protocols: 100 mcg/day x 6-7 days → 100 mcg alternate days x 7 doses → 100 mcg every 3-4 days x 2-3 weeks

• 100-1000 mcg IM once monthly for life
• If patient is symptom-free on monthly dosing, continue monthly

Maintenance therapy consists of 100-1000 mcg intramuscularly once a month for life. - Katzung's Basic and Clinical Pharmacology, 16th Ed.

With Neurological Involvement (Subacute Combined Degeneration)

• Loading as above
• Maintenance: 100-1000 mcg IM every 1-2 weeks x 6 months, then switch to monthly injections
• Neurological recovery may take months; do not discontinue early

If neurological abnormalities are present, maintenance therapy injections should be given every 1-2 weeks for 6 months before switching to monthly injections. - Katzung's

Diabetic Peripheral Neuropathy (Common Indian clinical practice)

• 500 mcg IM 3 times per week x 4-8 weeks, then switch to oral maintenance
• A 2023 meta-analysis (PMID 37920836) evaluated acupoint injection of mecobalamin vs. standard IM in diabetic peripheral neuropathy - acupoint route showed added benefit, though standard IM remains the primary approach

General Nutritional Deficiency (without malabsorption)

• Short-term parenteral loading, then transition to oral methylcobalamin 500-1500 mcg/day
• High-dose oral (1000-2000 mcg/day) is effective once deficiency is corrected if GI absorption is intact

Monitoring

Contraindications & Precautions

• No absolute contraindications to methylcobalamin itself
• Hypersensitivity to cobalamin or cobalt (rare)
• Leber's hereditary optic neuropathy: cyanocobalamin (not methylcobalamin) may worsen optic atrophy, but methylcobalamin is generally considered safe
• Polycythemia vera: high-dose B12 can trigger rapid RBC production - use with caution
• Hypokalemia risk: when treating severe megaloblastic anemia, rapid cell regeneration can cause sudden drop in serum potassium - monitor K+ closely

Drug Interactions

Special Populations

When to Prefer Oral Over Injection

• Oral/sublingual methylcobalamin 500-1500 mcg/day is as effective as monthly IM for maintenance
• Sublingual has similar bioavailability to IM for correcting serum B12 levels
• Oral is preferred for cost-effectiveness and patient comfort in long-term management

Key Clinical Pearls

1. Treat with B12 first, not folate alone - giving folic acid to a B12-deficient patient may improve the anemia but allow the neurological damage to progress silently
2. Neurological damage from B12 deficiency can be irreversible if untreated - do not delay
3. Serum B12 level can be normal yet tissue deficiency exists (especially with liver disease) - methylmalonic acid is more sensitive
4. B12 deficiency must be considered in elderly patients with dementia even without anemia